Researchers at Yale published a new study titled “Acute and Longer-Term Outcomes Using Ketamine as a Clinical Treatment at the Yale Psychiatric Hospital” in Clinical Psychiatry. In late 2014, Yale began providing ketamine as an off-label therapy on a...
CNN featured a segment on the use of ketamine for treating suicidal ideation–a novel, off-label use for ketamine that is currently being explored in human clinical trials. The segment featured Dr. Sanjay Gupta sharing the story of Alan Ferguson. Mr....
Australian researchers completed the world’s first randomized control trial (RCT), assessing the efficacy and safety of ketamine as a treatment for depression in elderly patients. In this double-blind, controlled, multiple-crossover study with a 6-month follow-up, 16...
Depression affects approximately one in five Americans and while most people respond to antidepressant medications, 1/3 will not. However, emerging research and countless case studies have shown that intravenous (IV) Ketamine is an effective depression treatment....
IV Ketamine has shown to be rapidly effective in treating PTSD in a recent study conducted by Emory University. In the first day after treatment, mean scores on the Impact of Event Scale-Revised (IES-R) fell to 14 from 46 at baseline following the IV ketamine...
